Open Label Extension Study of Elobixibat in Constipation - Echo 3

• Research type

  Research Study

• Full title

  A Multicenter, Open-label, Safety and Tolerability Extension Trial of 5mg and 10 mg Elobixibat Daily in the Treatment of Chronic Idiopathic Constipation

• IRAS ID

  126401

• Contact name

  Essam Abdulhakim

• Contact email

  essam.hakim@synexus.com

• Sponsor organisation

  Ferring International Pharmascience Center US, Inc.

• Eudract number

  2012-005601-46

• ISRCTN Number

  n/a

• Clinicaltrials.gov Identifier

  n/a

• REC name

  East Midlands - Nottingham 2 Research Ethics Committee

• REC reference

  13/EM/0137

• Date of REC Opinion

  26 Apr 2013

• REC opinion

  Favourable Opinion